Skip to main content
HEOR

Select a fit-for-purpose health economics and outcomes research consulting partner

We ensure optimal value demonstration for innovative health technologies through a uniquely flexible, end-to-end HEOR consulting team solution powered by therapeutic knowledge, tech-enabled insights, and methodological expertise.

pharma HEOR services

Our evidence solutions include:

Strategy
  • HEOR, value and access (including pricing)
  • Integrated evidence planning (IEP)
  • Value proposition/value story/evidence gap analysis
  • HEOR/HTA advisory boards
  • Appraisal review/HTA/scientific advice
  • Outcomes-based contracting
Landscape
  • Competitive landscape
  • Pricing and reimbursement landscape assessment
  • Analog assessment
  • PRO landscape
  • Policy landscape
Generation
  • Rapid evidence synthesis/Disease state profiling
  • Disease model
  • Economic model (BIM, CEM, Breakeven model)
  • Cost calculator
  • Global patient funnel
  • Model adaptations
  • Meta analysis and indirect comparisons
  • Preference survey
Communication
  • Value dossiers (GVD, AMCP)
  • Tool and resources for customer-facing teams (MSL, HOLs, AM)
  • Response letter and submissions to HTAs
  • Objection handlers
  • Access playbook
  • Integrated Evidence Generation Planning playbook
Genesis Research Group - offerings mix

The power of an integrated approach

Led by professionals with experience as both consultants and within pharma, biotech, and medical device organizations, the depth and breadth of our expertise enables us to offer a one-stop solution for all your health economics and outcomes research consulting needs, from strategic evidence generation planning to Health Technology Assessment (HTA) support, and methodological specialization.

Get in Touch

“We are impressed with the efficiency and quality of the work, your leadership skills, and the extra efforts you've made to ensure the results are absolutely accurate."

HEOR/RWE client

Therapeutic areas

Our team possesses deep knowledge across therapeutic areas, further details of which as can be explored through our selected publications list.

  • Autoimmune
  • Cardiology
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • General medicine
  • Hematology
  • Hematology/oncology
  • Immunology
  • Infectious diseases
  • Mental health
  • Musculoskeletal
  • Nephrology/ Renal disease
  • Neurology
  • Obesity
  • Obstetrics/ Gynecology
  • Oncology
  • Ophthalmology
  • Pain
  • Psychiatry
  • Pulmonology/ Respiratory
  • Radiology
  • Rheumatology
  • Urology

Looking for a comprehensive solution to your health economics and outcomes research challenges?

Get in touch
fit for purpose expertise team
light bulb overlay
blue circle
Flexible Integrated Teams (FIT)

Research partnerships reimagined

Many clients seeking HEOR support choose to take advantage of our optional FIT engagement model, which provides dedicated, cross-functional teams that integrate seamlessly within your own to fill experience gaps or supplement existing resources.

The size and composition of your team can gradually evolve or quickly pivot to meet your changing needs, all without the costly delays involved in adjusting a statement of work.

A trusted extension of your organization, our team becomes your team.

Learn more
Accelerated Insight Generation

Where agile technology meets HEOR expertise

Our expert HEOR teams leverage a suite of technology platforms to optimize evidence generation and communication.

EVID AI enhances and accelerates literature reviews; RPR secures robust stakeholder insights at any stage of the process; and our interactive RWE Dashboards transform complex data into digestible insights.

Additionally, we have developed Integrated Evidence Planning platforms to meet the challenge of evidence organization and communication, providing optimal visibility to internal stakeholders and ensuring proper alignment across functional and geographic teams.

Explore our technology

Tech-enabled HEOR

Rapid stakeholder insights

RPR platform
Rapid Payer Response logo
Technology-infused research

Trust the voice of the stakeholder to test your evidence strategy and optimize market access

High quality engagement with payers and other stakeholders can significantly enhance decision-making at all stages of product development. We are able to provide clients with both a global, vetted stakeholder network and a transparent online platform to facilitate this engagement.

  • Leverage our agile, tech-enabled RPR platform to develop robust market access strategies and fit-for-purpose evidence-generation plans.
  • Secure critical payer, key opinion leader (KOL), patient advocacy group, and policy maker insights across the product lifecycle.
  • Engage with a global network of 3,000+ vetted stakeholders across 65+ countries to test your market access and evidence strategies as they evolve.
Learn more
HEOR Case Study

Focal segmental glomerulosclerosis: evaluate HCRU and burden of illness

Focal segmental glomerulosclerosis (FSGS) is a varied, complex pattern of kidney damage that has several different causes and numerous names and terminology, as well as different proposed classification systems.

Evidence generation required (1.) claims to summarize the cost and HCRU burden and (2.) clinical data (e.g. labs from EHR) to accurately identify patients in the study cohort.

We collaborated with the client to develop a protocol and analysis plan.

Download full case study

Genesis Research Hub

Publications

Explore our publications for details of our peer-reviewed research and therapeutic experience.

Insights

Delve deeper into Genesis Research: videos, interviews, papers, webinars, and case studies.

News & Events

Check out our latest news and events. We hope to see you soon at an upcoming show or webinar!

Case studies

How our approach, expertise, and research capabilities have impacted upon our clients' success.

Newsletter

Keep current on the latest research and learn more about our work by signing up to our newsletter.